Report on stage III Pig-a mutation assays using N-ethyl-N-nitrosourea - comparison with other in vivo genotoxicity endpoints

N‐Ethyl‐N‐nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig‐a gene mutation assay. Groups of six‐ to eight‐week‐old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and eva...

Full description

Saved in:
Bibliographic Details
Published inEnvironmental and molecular mutagenesis Vol. 52; no. 9; pp. 721 - 730
Main Authors Cammerer, Zoryana, Bhalli, Javed A., Cao, Xuefei, Coffing, Stephanie L., Dickinson, Donna, Dobo, Krista L., Dobrovolsky, Vasily N., Engel, Maria, Fiedler, Ronald D., Gunther, William C., Heflich, Robert H., Pearce, Mason G., Shaddock, Joseph G., Shutsky, Thomas, Thiffeault, Catherine J., Schuler, Maik
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.12.2011
Wiley-Liss
Subjects
Online AccessGet full text

Cover

Loading…
Abstract N‐Ethyl‐N‐nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig‐a gene mutation assay. Groups of six‐ to eight‐week‐old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day‐1) and at various time points up to Day 57. Pig‐a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBCCD59− and RETCD59− frequencies. Consistent with the results from a reference laboratory, RBCCD59− and RETCD59− frequencies increased in a dose‐ and time‐dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU‐treated SD rats. Hprt and Pig‐a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two‐ to fourfold stronger responses for Hprt than Pig‐a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig‐a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28‐day repeat‐dose rat studies. © Environ. Mol. Mutagen. 2011. Published 2011 Wiley‐Liss, Inc.
AbstractList N ‐Ethyl‐ N ‐nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig‐a gene mutation assay. Groups of six‐ to eight‐week‐old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day‐1) and at various time points up to Day 57. Pig‐a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBC CD59− and RET CD59− frequencies. Consistent with the results from a reference laboratory, RBC CD59− and RET CD59− frequencies increased in a dose‐ and time‐dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU‐treated SD rats. Hprt and Pig‐a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two‐ to fourfold stronger responses for Hprt than Pig‐a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig‐a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28‐day repeat‐dose rat studies. © Environ. Mol. Mutagen. 2011. Published 2011 Wiley‐Liss, Inc.
N-Ethyl-N-nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig-a gene mutation assay. Groups of six- to eight-week-old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day-1) and at various time points up to Day 57. Pig-a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBC(CD592-) and RET(CD592-) frequencies. Consistent with the results from a reference laboratory, RBC(CD592-) and RET(CD592-) frequencies increased in a dose and time-dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU-treated SD rats. Hprt and Pig-a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two- to fourfold stronger responses for Hprt than Pig-a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig-a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28-day repeat dose rat studies.
N‐Ethyl‐N‐nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig‐a gene mutation assay. Groups of six‐ to eight‐week‐old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day‐1) and at various time points up to Day 57. Pig‐a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBCCD59− and RETCD59− frequencies. Consistent with the results from a reference laboratory, RBCCD59− and RETCD59− frequencies increased in a dose‐ and time‐dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU‐treated SD rats. Hprt and Pig‐a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two‐ to fourfold stronger responses for Hprt than Pig‐a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig‐a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28‐day repeat‐dose rat studies. © Environ. Mol. Mutagen. 2011. Published 2011 Wiley‐Liss, Inc.
N-Ethyl-N-nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig-a gene mutation assay. Groups of six- to eight-week-old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day-1) and at various time points up to Day 57. Pig-a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBCCD59- and RETCD59- frequencies. Consistent with the results from a reference laboratory, RBCCD59- and RETCD59- frequencies increased in a dose- and time-dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU-treated SD rats. Hprt and Pig-a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two- to fourfold stronger responses for Hprt than Pig-a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig-a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28-day repeat-dose rat studies. ? Environ. Mol. Mutagen. 2011. Published 2011 Wiley-Liss, Inc.
N-Ethyl-N-nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig-a gene mutation assay. Groups of six- to eight-week-old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day-1) and at various time points up to Day 57. Pig-a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBC(CD592-) and RET(CD592-) frequencies. Consistent with the results from a reference laboratory, RBC(CD592-) and RET(CD592-) frequencies increased in a dose and time-dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU-treated SD rats. Hprt and Pig-a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two- to fourfold stronger responses for Hprt than Pig-a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig-a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28-day repeat dose rat studies.N-Ethyl-N-nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig-a gene mutation assay. Groups of six- to eight-week-old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day-1) and at various time points up to Day 57. Pig-a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBC(CD592-) and RET(CD592-) frequencies. Consistent with the results from a reference laboratory, RBC(CD592-) and RET(CD592-) frequencies increased in a dose and time-dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU-treated SD rats. Hprt and Pig-a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two- to fourfold stronger responses for Hprt than Pig-a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig-a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28-day repeat dose rat studies.
Author Shutsky, Thomas
Pearce, Mason G.
Thiffeault, Catherine J.
Gunther, William C.
Cao, Xuefei
Dobrovolsky, Vasily N.
Heflich, Robert H.
Dickinson, Donna
Dobo, Krista L.
Engel, Maria
Shaddock, Joseph G.
Bhalli, Javed A.
Fiedler, Ronald D.
Schuler, Maik
Coffing, Stephanie L.
Cammerer, Zoryana
Author_xml – sequence: 1
  givenname: Zoryana
  surname: Cammerer
  fullname: Cammerer, Zoryana
  organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350
– sequence: 2
  givenname: Javed A.
  surname: Bhalli
  fullname: Bhalli, Javed A.
  organization: Division of Genetic and Molecular Toxicology, U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079
– sequence: 3
  givenname: Xuefei
  surname: Cao
  fullname: Cao, Xuefei
  organization: Division of Genetic and Molecular Toxicology, U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079
– sequence: 4
  givenname: Stephanie L.
  surname: Coffing
  fullname: Coffing, Stephanie L.
  organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350
– sequence: 5
  givenname: Donna
  surname: Dickinson
  fullname: Dickinson, Donna
  organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350
– sequence: 6
  givenname: Krista L.
  surname: Dobo
  fullname: Dobo, Krista L.
  organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350
– sequence: 7
  givenname: Vasily N.
  surname: Dobrovolsky
  fullname: Dobrovolsky, Vasily N.
  organization: Division of Genetic and Molecular Toxicology, U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079
– sequence: 8
  givenname: Maria
  surname: Engel
  fullname: Engel, Maria
  organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350
– sequence: 9
  givenname: Ronald D.
  surname: Fiedler
  fullname: Fiedler, Ronald D.
  organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350
– sequence: 10
  givenname: William C.
  surname: Gunther
  fullname: Gunther, William C.
  organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350
– sequence: 11
  givenname: Robert H.
  surname: Heflich
  fullname: Heflich, Robert H.
  organization: Division of Genetic and Molecular Toxicology, U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079
– sequence: 12
  givenname: Mason G.
  surname: Pearce
  fullname: Pearce, Mason G.
  organization: Division of Genetic and Molecular Toxicology, U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079
– sequence: 13
  givenname: Joseph G.
  surname: Shaddock
  fullname: Shaddock, Joseph G.
  organization: Division of Genetic and Molecular Toxicology, U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079
– sequence: 14
  givenname: Thomas
  surname: Shutsky
  fullname: Shutsky, Thomas
  organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350
– sequence: 15
  givenname: Catherine J.
  surname: Thiffeault
  fullname: Thiffeault, Catherine J.
  organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350
– sequence: 16
  givenname: Maik
  surname: Schuler
  fullname: Schuler, Maik
  email: maik.schuler@pfizer.com
  organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25245702$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22167886$$D View this record in MEDLINE/PubMed
BookMark eNp90U1v0zAYB3ALDbGuIPEJkC8ILi5-SRz7yKYxKo2C0Hi5WU7itIbELrazLRIfHrN2m4SAkw_--f9Y_-cIHDjvDABPCV4QjOkrMywo5oI_ADOCpUCUCnwAZlhIhjiX9BAcxfgNY0IKSR-BQ0oJr4TgM_Dzo9n6kKB3MCa9NnC5XMIPdo00HMakk80XOkY9RThG69ZwhUzaTD1aIWdT8NGPwWiIYOOHrQ42Zn9l0wb6tDEBWgcv7aWHa-N88te2sWmCxrVbb12Kj8HDTvfRPNmfc_DpzenFyVt0_v5sefL6HDVF_iiqWtky0bKaNQXHklScaInLGneMFrTFApNSNrwuC1loKg0hVBQ1pbqUXVe3FZuDF7vcbfA_RhOTGmxsTN9rZ_wYlSREspJQnuXL_0qCc7M0jy0zfbanYz2YVm2DHXSY1G23GTzfAx0b3XdBu8bGe1fmlCqHzcFi55pcZwymU7mlm-ZT0LbPM9XvJSszqJsl33_y7sFt5l8o2tEr25vpn06dvvvD25jM9Z3X4bviFatK9WV1poqv1TEVn5m6YL8AZ6zCKw
CODEN EMMUEG
CitedBy_id crossref_primary_10_1002_em_22232
crossref_primary_10_1002_em_20692
crossref_primary_10_1002_em_21981
crossref_primary_10_1002_em_22211
crossref_primary_10_1002_em_21862
crossref_primary_10_1093_mutage_gev077
crossref_primary_10_1002_em_20675
crossref_primary_10_1002_em_21863
crossref_primary_10_1016_j_fct_2018_10_061
crossref_primary_10_1093_mutage_gev013
crossref_primary_10_1002_em_21724
crossref_primary_10_1002_em_21825
crossref_primary_10_1002_em_21924
crossref_primary_10_1002_em_21709
crossref_primary_10_1016_j_mrgentox_2014_12_001
crossref_primary_10_3123_jemsge_2014_027
crossref_primary_10_1002_em_22060
crossref_primary_10_3123_jemsge_2014_023
crossref_primary_10_1016_j_mrgentox_2013_03_002
crossref_primary_10_1093_mutage_geu051
crossref_primary_10_1002_em_20685
crossref_primary_10_1093_mutage_geu055
crossref_primary_10_1007_s00204_018_2157_4
crossref_primary_10_1093_mutage_get022
crossref_primary_10_1002_em_21910
crossref_primary_10_1093_mutage_gew059
crossref_primary_10_1016_j_mrgentox_2016_10_003
crossref_primary_10_1093_mutage_gev005
crossref_primary_10_1002_em_22109
crossref_primary_10_1016_j_mrgentox_2015_12_005
crossref_primary_10_1007_s00204_014_1413_5
crossref_primary_10_1002_em_21818
crossref_primary_10_1016_j_mrgentox_2014_09_007
crossref_primary_10_2131_jts_37_943
crossref_primary_10_1093_toxsci_kfs258
Cites_doi 10.1016/j.toxlet.2009.04.003
10.1016/j.mrgentox.2010.02.009
10.1016/j.toxlet.2009.03.021
10.1016/j.mrgentox.2011.06.005
10.1093/toxsci/kfp289
10.1016/j.mrgentox.2011.02.009
10.1002/em.20379
10.1002/em.20413
10.1158/0008-5472.CAN-06-4061
10.1159/000077506
10.1093/mutage/gen015
10.1016/S1383-5718(97)00144-7
10.1002/em.20675
10.1016/j.mrgentox.2009.05.014
10.2307/2530051
10.1016/S0027-5107(00)00065-8
10.1002/em.20616
10.1016/j.toxlet.2009.03.008
10.1093/toxsci/kfq070
ContentType Journal Article
Copyright Copyright © 2011 Wiley‐Liss, Inc.
2015 INIST-CNRS
Copyright_xml – notice: Copyright © 2011 Wiley‐Liss, Inc.
– notice: 2015 INIST-CNRS
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7U7
8FD
C1K
FR3
P64
RC3
7X8
DOI 10.1002/em.20686
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Engineering Research Database
Technology Research Database
Toxicology Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE

Genetics Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1098-2280
EndPage 730
ExternalDocumentID 22167886
25245702
10_1002_em_20686
EM20686
ark_67375_WNG_4X7B28V3_T
Genre article
Comparative Study
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIH‐NIEHS
  funderid: R44ES015940
– fundername: Oak Ridge Institute for Science and Education
– fundername: NIEHS NIH HHS
  grantid: R44ES015940
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
A8Z
AAESR
AAEVG
AAHHS
AAIKC
AAMNW
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEFU
ABEML
ABIJN
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AI.
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBD
EBS
EDH
EJD
EMOBN
ESTFP
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LITHE
LOXES
LP6
LP7
LUTES
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
SAMSI
SUPJJ
SV3
TEORI
TN5
UB1
V2E
VH1
W8V
W99
WBKPD
WIB
WIH
WIJ
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WUP
WWO
WXI
WXSBR
WYISQ
XG1
XV2
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
-
0R
31
3N
AAPBV
AAVGM
ABFLS
ABHUG
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
GA
HZ
IA
IPNFZ
KM
NF
P4A
PQEST
RIG
WT
Y3
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
AAYXX
ACRPL
ACYXJ
ADNMO
AEYWJ
AFWVQ
AGHNM
AGQPQ
AGYGG
ALVPJ
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7U7
8FD
C1K
FR3
P64
RC3
7X8
ID FETCH-LOGICAL-c4216-7d9d38d3b3c46091761a905b0f3242d080159c6b5494a29e11284b22a59ffbd73
IEDL.DBID DR2
ISSN 0893-6692
1098-2280
IngestDate Thu Jul 10 18:29:46 EDT 2025
Fri Jul 11 05:20:08 EDT 2025
Mon Jul 21 06:02:03 EDT 2025
Mon Jul 21 09:14:46 EDT 2025
Tue Jul 01 01:44:45 EDT 2025
Thu Apr 24 23:07:56 EDT 2025
Fri Jun 04 19:44:38 EDT 2021
Wed Oct 30 09:56:29 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Flow cytometry
Rat
Toxicity
Nitrosoureas
Glycosyltransferases
Genotoxicity
Hprt
Hypoxanthine phosphoribosyltransferase
Comet assay
micronucleus assay
Gene
Micronucleus
CD59
rats
Ungulata
Enzyme
Report
Mutagenicity testing
Transferases
gene mutation
Rodentia
reticulocytes
Pig
In vivo
Vertebrata
Mammalia
Reticulocyte
Artiodactyla
Mutation
Pentosyltransferases
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4216-7d9d38d3b3c46091761a905b0f3242d080159c6b5494a29e11284b22a59ffbd73
Notes NIH-NIEHS - No. R44ES015940
Oak Ridge Institute for Science and Education
ArticleID:EM20686
istex:249B1734DD0E3FA20018DA1FC76C6A9FED3F431D
ark:/67375/WNG-4X7B28V3-T
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 22167886
PQID 1028023245
PQPubID 23462
PageCount 10
ParticipantIDs proquest_miscellaneous_911935126
proquest_miscellaneous_1028023245
pubmed_primary_22167886
pascalfrancis_primary_25245702
crossref_citationtrail_10_1002_em_20686
crossref_primary_10_1002_em_20686
wiley_primary_10_1002_em_20686_EM20686
istex_primary_ark_67375_WNG_4X7B28V3_T
ProviderPackageCode 10A
A01
RJQFR
A03
ADOZA
BFHJK
DRMAN
BROTX
AMBMR
DCZOG
MRMAN
~IA
ACAHQ
LEEKS
AFGKR
50Y
50Z
AEUQT
XG1
AAEVG
MRSTM
ACMXC
.3N
MEWTI
1ZS
AAVGM
Q11
LP7
H.X
LP6
WUP
51W
51X
ACXME
WBKPD
QB0
ADMGS
UB1
AEIMD
GNP
ATUGU
DUUFO
WOHZO
G-S
KBYEO
O66
AZBYB
52M
3WU
52N
52O
52P
ADEOM
LATKE
ZZTAW
52R
52S
930
BAFTC
52T
MK4
QRW
SUPJJ
52U
HHY
52V
52W
DRSTM
1L6
52X
HHZ
AFPWT
ALAGY
DR2
G.N
ACPOU
AFZJQ
WWO
ADAWD
702
7PT
66C
NNB
ADIZJ
.GA
WXI
AAONW
LYRES
GODZA
HBH
LUTES
ALUQN
AAZKR
MSFUL
LC2
AIURR
LC3
AZVAB
WNSPC
RWI
PALCI
ABHUG
KQQ
RX1
ACXQS
BMXJE
R.K
WIB
WQJ
MXFUL
P2W
W8V
W99
WYISQ
FUBAC
MSMAN
P2X
WIH
WIK
P2Z
WIJ
JPC
BDRZF
BY8
MSSTM
DPXWK
1OB
1OC
3SF
F01
F00
NF~
BRXPI
MXMAN
WRC
AFVGU
F04
ADZMN
8UM
ABCUV
N05
N04
ADDAD
WJL
~WT
8-0
8-1
P4A
8-3
AGJLS
8-4
P4B
8-5
P4D
IX1
BHBCM
LITHE
SAMSI
J0M
MXSTM
DRFUL
D-6
D-7
33P
Q.N
05W
XV2
AAESR
LOXES
MRFUL
D-F
D-E
AIACR
CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2011
PublicationDateYYYYMMDD 2011-12-01
PublicationDate_xml – month: 12
  year: 2011
  text: December 2011
PublicationDecade 2010
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: Hoboken, NJ
– name: United States
PublicationTitle Environmental and molecular mutagenesis
PublicationTitleAlternate Environ. Mol. Mutagen
PublicationYear 2011
Publisher Wiley Subscription Services, Inc., A Wiley Company
Wiley-Liss
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
– name: Wiley-Liss
References Miura D,Dobrovolsky VN,Kimoto T,Kasahara Y,Heflich RH. 2009. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat Res 677(1-2): 86-92.
Suzuki H,Shirotori T,Hayashi M. 2004. A liver micronucleus assay using young rats exposed to diethylnitrosamine: Methodological establishment and evaluation. Cytogenet Genome Res 104(1-4): 299-303.
Gocke E,Ballantyne M,Whitwell J,Muller L. 2009. MNT and MutaMouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU. Toxicol Lett 190: 286-297.
Gocke E,Wall M. 2009. In vivo genotoxicity of EMS: Statistical assessment of the dose response curves. Toxicol Lett 190: 298-302.
Jansen JG,Vrieling H,van Teijlingen CM,Mohn GR,Tates AD,van Zeeland AA. 1995. Marked differences in the role of O6-alkylguanine in hprt mutagenesis in T-lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N-(2-hydroxyethyl)-N-nitrosourea, or N-ethyl-N-nitrosourea. Cancer Res 55: 1875-1882.
Bhalli JA,Shaddock JG,Pearce MG,Dobrovolsky VN,Cao X,Heflich RH,Vohr H-W. 2011. Report on Stage III Pig-a mutations assays using benzo[a]pyrene. Environ Mol Mutagenesis, 52: 731-737.
Coffing S,Engel M,Dickinson D,Thiffeault C,Spellman R,Shutsky T,Schuler M. 2011. The rat gut micronucleus assay: A good choice for alternative in vivo genetic toxicology testing strategies. Environ Mol Mutagen 52: 269-279.
Bryce SM,Bemis JC,Dertinger SD. 2008. In vivo mutation assay based on the endogenous Pig-a locus. Environ Mol Mutagen 49: 256-264.
Muller L,Gocke E,Lave T,Pfister T. 2009. Ethyl methanesulfonate toxicity in Viracept-A comprehensive human risk assessment based on threshold data for genotoxicity. Toxicol Lett 190: 317-329.
Dertinger SD,Phonethepswath S,Franklin D,Weller P,Torous DK,Bryce SM,Avlasevich S,Bemis JC,Hyrien O,Palis J,MacGregor JT. 2010. Integration of mutation and chromosomal damage endpoints into 28-day repeat dose toxicology studies. Toxicol Sci 115: 401-411.
Fenech M. 2000. The in vitro micronucleus technique. Mutat Res 455(1-2): 81-95.
Phonethepswath S,Franklin D,Torous DK,Bryce SM,Bemis JC,Raja S,Avlasevich S,Weller P,Hyrien O,Palis J,Macgregor JT,Dertinger SD. 2010. Pig-a mutation: Kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol Sci 114: 59-70.
Doak SH,Jenkins GJ,Johnson GE,Quick E,Parry EM,Parry JM. 2007. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res 67: 3904-3911.
Lovell DP,Omori T. 2008. Statistical issues in the use of the comet assay. Mutagenesis 23: 171-182.
Suzuki T,Hayashi M,Wang X,Yamamoto K,Ono T,Myhr BC,Sofuni T. 1997. A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta Mouse). Mutat Res 395: 75-82.
Takasawa H,Suzuki H,Ogawa I,Shimada Y,Kobayashi K,Terashima Y,Matsumoto H,Aruga C,Oshida K,Ohta R,Imamura T,Miyazaki A,Kawabata M,Minowa S,Hayashi M. 2010. Evaluation of a liver micronucleus assay in young rats (III): A study using nine hepatotoxicants by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)-Mammalian Mutagenicity Study Group (MMS). Mutat Res 698(1-2): 30-37.
Bowen DE,Whitwell JH,Lillford L,Henderson D,Kidd D,Mc Garry S,Pearce G,Beevers C,Kirkland DJ. 2011. Evaluation of a multi-endpoint assay in rats, combining the bone-marrow micronucleus test, the Comet assay and the flow-cytometric peripheral blood micronucleus test. Mutat Res 722: 7-19.
Dobo KL,Fiedler RD,Gunther WC,Thiffeault CJ,Cammerer Z,Coffing SL,Shutsky T,Schuler M. 2011. Defining EMS and ENU dose-response relationships using the pig-a mutation assay in rats. Mutat Res 725:13-21.
Miura D,Dobrovolsky VN,Mittelstaedt RA,Kasahara Y,Katsuura Y,Heflich RH. 2008. Development of an in vivo gene mutation assay using the endogenous Pig-A gene. II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Environ Mol Mutagen 49: 622-630.
Conover WJ,Iman RL. 1982. Analysis of covariance using the rank transformation. Biometrics 38: 715-724.
1982; 38
2011; 725
2004; 104
2011; 722
2009; 190
2000; 455
2010; 114
1997; 395
2010; 115
2010; 698
2008; 49
1995; 55
2011; 52
2008; 23
2007; 67
2009; 677
e_1_2_6_21_1
e_1_2_6_10_1
e_1_2_6_20_1
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_19_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_14_1
e_1_2_6_3_1
e_1_2_6_11_1
Jansen JG (e_1_2_6_13_1) 1995; 55
e_1_2_6_2_1
e_1_2_6_12_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
References_xml – reference: Coffing S,Engel M,Dickinson D,Thiffeault C,Spellman R,Shutsky T,Schuler M. 2011. The rat gut micronucleus assay: A good choice for alternative in vivo genetic toxicology testing strategies. Environ Mol Mutagen 52: 269-279.
– reference: Conover WJ,Iman RL. 1982. Analysis of covariance using the rank transformation. Biometrics 38: 715-724.
– reference: Jansen JG,Vrieling H,van Teijlingen CM,Mohn GR,Tates AD,van Zeeland AA. 1995. Marked differences in the role of O6-alkylguanine in hprt mutagenesis in T-lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N-(2-hydroxyethyl)-N-nitrosourea, or N-ethyl-N-nitrosourea. Cancer Res 55: 1875-1882.
– reference: Dobo KL,Fiedler RD,Gunther WC,Thiffeault CJ,Cammerer Z,Coffing SL,Shutsky T,Schuler M. 2011. Defining EMS and ENU dose-response relationships using the pig-a mutation assay in rats. Mutat Res 725:13-21.
– reference: Suzuki T,Hayashi M,Wang X,Yamamoto K,Ono T,Myhr BC,Sofuni T. 1997. A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta Mouse). Mutat Res 395: 75-82.
– reference: Gocke E,Wall M. 2009. In vivo genotoxicity of EMS: Statistical assessment of the dose response curves. Toxicol Lett 190: 298-302.
– reference: Phonethepswath S,Franklin D,Torous DK,Bryce SM,Bemis JC,Raja S,Avlasevich S,Weller P,Hyrien O,Palis J,Macgregor JT,Dertinger SD. 2010. Pig-a mutation: Kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol Sci 114: 59-70.
– reference: Gocke E,Ballantyne M,Whitwell J,Muller L. 2009. MNT and MutaMouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU. Toxicol Lett 190: 286-297.
– reference: Lovell DP,Omori T. 2008. Statistical issues in the use of the comet assay. Mutagenesis 23: 171-182.
– reference: Suzuki H,Shirotori T,Hayashi M. 2004. A liver micronucleus assay using young rats exposed to diethylnitrosamine: Methodological establishment and evaluation. Cytogenet Genome Res 104(1-4): 299-303.
– reference: Bhalli JA,Shaddock JG,Pearce MG,Dobrovolsky VN,Cao X,Heflich RH,Vohr H-W. 2011. Report on Stage III Pig-a mutations assays using benzo[a]pyrene. Environ Mol Mutagenesis, 52: 731-737.
– reference: Doak SH,Jenkins GJ,Johnson GE,Quick E,Parry EM,Parry JM. 2007. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res 67: 3904-3911.
– reference: Takasawa H,Suzuki H,Ogawa I,Shimada Y,Kobayashi K,Terashima Y,Matsumoto H,Aruga C,Oshida K,Ohta R,Imamura T,Miyazaki A,Kawabata M,Minowa S,Hayashi M. 2010. Evaluation of a liver micronucleus assay in young rats (III): A study using nine hepatotoxicants by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)-Mammalian Mutagenicity Study Group (MMS). Mutat Res 698(1-2): 30-37.
– reference: Fenech M. 2000. The in vitro micronucleus technique. Mutat Res 455(1-2): 81-95.
– reference: Miura D,Dobrovolsky VN,Kimoto T,Kasahara Y,Heflich RH. 2009. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat Res 677(1-2): 86-92.
– reference: Muller L,Gocke E,Lave T,Pfister T. 2009. Ethyl methanesulfonate toxicity in Viracept-A comprehensive human risk assessment based on threshold data for genotoxicity. Toxicol Lett 190: 317-329.
– reference: Miura D,Dobrovolsky VN,Mittelstaedt RA,Kasahara Y,Katsuura Y,Heflich RH. 2008. Development of an in vivo gene mutation assay using the endogenous Pig-A gene. II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Environ Mol Mutagen 49: 622-630.
– reference: Bowen DE,Whitwell JH,Lillford L,Henderson D,Kidd D,Mc Garry S,Pearce G,Beevers C,Kirkland DJ. 2011. Evaluation of a multi-endpoint assay in rats, combining the bone-marrow micronucleus test, the Comet assay and the flow-cytometric peripheral blood micronucleus test. Mutat Res 722: 7-19.
– reference: Bryce SM,Bemis JC,Dertinger SD. 2008. In vivo mutation assay based on the endogenous Pig-a locus. Environ Mol Mutagen 49: 256-264.
– reference: Dertinger SD,Phonethepswath S,Franklin D,Weller P,Torous DK,Bryce SM,Avlasevich S,Bemis JC,Hyrien O,Palis J,MacGregor JT. 2010. Integration of mutation and chromosomal damage endpoints into 28-day repeat dose toxicology studies. Toxicol Sci 115: 401-411.
– volume: 722
  start-page: 7
  year: 2011
  end-page: 19
  article-title: Evaluation of a multi‐endpoint assay in rats, combining the bone‐marrow micronucleus test, the Comet assay and the flow‐cytometric peripheral blood micronucleus test
  publication-title: Mutat Res
– volume: 52
  start-page: 731
  year: 2011
  end-page: 737
  article-title: Report on Stage III mutations assays using benzo[ ]pyrene
  publication-title: Environ Mol Mutagenesis
– volume: 190
  start-page: 298
  year: 2009
  end-page: 302
  article-title: In vivo genotoxicity of EMS: Statistical assessment of the dose response curves
  publication-title: Toxicol Lett
– volume: 23
  start-page: 171
  year: 2008
  end-page: 182
  article-title: Statistical issues in the use of the comet assay
  publication-title: Mutagenesis
– volume: 190
  start-page: 286
  year: 2009
  end-page: 297
  article-title: MNT and MutaMouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU
  publication-title: Toxicol Lett
– volume: 455
  start-page: 81
  issue: 1–2
  year: 2000
  end-page: 95
  article-title: The in vitro micronucleus technique
  publication-title: Mutat Res
– volume: 190
  start-page: 317
  year: 2009
  end-page: 329
  article-title: Ethyl methanesulfonate toxicity in Viracept—A comprehensive human risk assessment based on threshold data for genotoxicity
  publication-title: Toxicol Lett
– volume: 725
  start-page: 13
  year: 2011
  end-page: 21
  article-title: Defining EMS and ENU dose‐response relationships using the pig‐a mutation assay in rats
  publication-title: Mutat Res
– volume: 115
  start-page: 401
  year: 2010
  end-page: 411
  article-title: Integration of mutation and chromosomal damage endpoints into 28‐day repeat dose toxicology studies
  publication-title: Toxicol Sci
– volume: 49
  start-page: 256
  year: 2008
  end-page: 264
  article-title: In vivo mutation assay based on the endogenous Pig‐a locus
  publication-title: Environ Mol Mutagen
– volume: 67
  start-page: 3904
  year: 2007
  end-page: 3911
  article-title: Mechanistic influences for mutation induction curves after exposure to DNA‐reactive carcinogens
  publication-title: Cancer Res
– volume: 49
  start-page: 622
  year: 2008
  end-page: 630
  article-title: Development of an in vivo gene mutation assay using the endogenous Pig‐A gene. II. Selection of Pig‐A mutant rat spleen T‐cells with proaerolysin and sequencing Pig‐A cDNA from the mutants
  publication-title: Environ Mol Mutagen
– volume: 55
  start-page: 1875
  year: 1995
  end-page: 1882
  article-title: Marked differences in the role of O6‐alkylguanine in hprt mutagenesis in T‐lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N‐(2‐hydroxyethyl)‐N‐nitrosourea, or N‐ethyl‐N‐nitrosourea
  publication-title: Cancer Res
– volume: 677
  start-page: 86
  issue: 1–2
  year: 2009
  end-page: 92
  article-title: Accumulation and persistence of Pig‐A mutant peripheral red blood cells following treatment of rats with single and split doses of N‐ethyl‐N‐nitrosourea
  publication-title: Mutat Res
– volume: 38
  start-page: 715
  year: 1982
  end-page: 724
  article-title: Analysis of covariance using the rank transformation
  publication-title: Biometrics
– volume: 104
  start-page: 299
  issue: 1–4
  year: 2004
  end-page: 303
  article-title: A liver micronucleus assay using young rats exposed to diethylnitrosamine: Methodological establishment and evaluation
  publication-title: Cytogenet Genome Res
– volume: 395
  start-page: 75
  year: 1997
  end-page: 82
  article-title: A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta Mouse)
  publication-title: Mutat Res
– volume: 114
  start-page: 59
  year: 2010
  end-page: 70
  article-title: Pig‐a mutation: Kinetics in rat erythrocytes following exposure to five prototypical mutagens
  publication-title: Toxicol Sci
– volume: 52
  start-page: 269
  year: 2011
  end-page: 279
  article-title: The rat gut micronucleus assay: A good choice for alternative in vivo genetic toxicology testing strategies
  publication-title: Environ Mol Mutagen
– volume: 698
  start-page: 30
  issue: 1–2
  year: 2010
  end-page: 37
  article-title: Evaluation of a liver micronucleus assay in young rats (III): A study using nine hepatotoxicants by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)‐Mammalian Mutagenicity Study Group (MMS)
  publication-title: Mutat Res
– ident: e_1_2_6_17_1
  doi: 10.1016/j.toxlet.2009.04.003
– ident: e_1_2_6_21_1
  doi: 10.1016/j.mrgentox.2010.02.009
– ident: e_1_2_6_11_1
  doi: 10.1016/j.toxlet.2009.03.021
– ident: e_1_2_6_9_1
  doi: 10.1016/j.mrgentox.2011.06.005
– volume: 55
  start-page: 1875
  year: 1995
  ident: e_1_2_6_13_1
  article-title: Marked differences in the role of O6‐alkylguanine in hprt mutagenesis in T‐lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N‐(2‐hydroxyethyl)‐N‐nitrosourea, or N‐ethyl‐N‐nitrosourea
  publication-title: Cancer Res
– ident: e_1_2_6_18_1
  doi: 10.1093/toxsci/kfp289
– ident: e_1_2_6_2_1
  doi: 10.1016/j.mrgentox.2011.02.009
– ident: e_1_2_6_4_1
  doi: 10.1002/em.20379
– ident: e_1_2_6_16_1
  doi: 10.1002/em.20413
– ident: e_1_2_6_8_1
  doi: 10.1158/0008-5472.CAN-06-4061
– ident: e_1_2_6_19_1
  doi: 10.1159/000077506
– ident: e_1_2_6_14_1
  doi: 10.1093/mutage/gen015
– ident: e_1_2_6_20_1
  doi: 10.1016/S1383-5718(97)00144-7
– ident: e_1_2_6_3_1
  doi: 10.1002/em.20675
– ident: e_1_2_6_15_1
  doi: 10.1016/j.mrgentox.2009.05.014
– ident: e_1_2_6_6_1
  doi: 10.2307/2530051
– ident: e_1_2_6_10_1
  doi: 10.1016/S0027-5107(00)00065-8
– ident: e_1_2_6_5_1
  doi: 10.1002/em.20616
– ident: e_1_2_6_12_1
  doi: 10.1016/j.toxlet.2009.03.008
– ident: e_1_2_6_7_1
  doi: 10.1093/toxsci/kfq070
SSID ssj0011492
Score 2.1633604
Snippet N‐Ethyl‐N‐nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig‐a gene mutation assay. Groups of six‐ to eight‐week‐old male Sprague...
N ‐Ethyl‐ N ‐nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig‐a gene mutation assay. Groups of six‐ to eight‐week‐old male...
N-Ethyl-N-nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig-a gene mutation assay. Groups of six- to eight-week-old male Sprague...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 721
SubjectTerms Animals
Biological and medical sciences
Calibration
CD59
CD59 Antigens - genetics
Colon - drug effects
Colon - ultrastructure
comet assay
Comet Assay - methods
Comet Assay - standards
Data Interpretation, Statistical
Diethylnitrosamine - toxicity
Dose-Response Relationship, Drug
Endpoint Determination
Erythrocytes - drug effects
Erythrocytes - ultrastructure
Flow Cytometry
Fundamental and applied biological sciences. Psychology
gene mutation
Genetics of eukaryotes. Biological and molecular evolution
Hprt
Liver - drug effects
Liver - ultrastructure
Male
Medical sciences
Membrane Proteins - genetics
micronucleus assay
Micronucleus Tests - methods
Micronucleus Tests - standards
Mutagenicity Tests - methods
Mutagenicity Tests - standards
Mutagens - toxicity
Mutation
Organ Specificity
Rats
Rats, Inbred F344
Rats, Sprague-Dawley
Reference Standards
Reproducibility of Results
reticulocytes
Reticulocytes - drug effects
Reticulocytes - ultrastructure
Species Specificity
Spleen - drug effects
Spleen - ultrastructure
Time Factors
Toxicology
Title Report on stage III Pig-a mutation assays using N-ethyl-N-nitrosourea - comparison with other in vivo genotoxicity endpoints
URI https://api.istex.fr/ark:/67375/WNG-4X7B28V3-T/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002/em.20686
https://www.ncbi.nlm.nih.gov/pubmed/22167886
https://www.proquest.com/docview/1028023245
https://www.proquest.com/docview/911935126
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb9QwEICtqhUSF2h5LtDKSAhOKVnHdpIjoD4WqSuEWlhOluM4q6htUjXZquXUE2ck_mF_SWfsTWBRKyFOWWknijMZez7b4xlCXmERkcRKHdhQmIBbieNgxINYW1aIQkYmwQPOe2O5e8A_TsRkiSTdWRifH6JfcMOe4cZr7OA6a-b7-uytxVPkMsFc2xiohTT0uc8bBYzvqiGH4IwDKVPWZZ3948YFP7SCKj3HuEjdgGoKX9PiJuhcZFjnhLbvk29d833syeHmrM02zfe_Mjv-z_utkntzMqXvvCmtkSVbPSB3fK3Ki4fkh0d1WlcUgHJq6Wg0op_K6dXlT02PZ35HnwKK64uGYjT9lI7hPwuGcARX_A2jB-iixjh4enX5i5q-BiLF5WDqDoPRsqJn5VlNMXtsW5-XBuYJ1Fb5SV1WbfOIHGxv7X_YDeZFHALD2VAGcZ7mUZJHWWS4BDiJ5VCnocjCAlEuB2AFoDIyg3kq1yy1Q3SYGWNapEWR5XH0mCxXdWWfEiphtlVkoWQ5HwJHmiQsAE9hysi5YHnMB-RN90mVmWc4x0IbR8rnZmbKHiun1QF52Uue-KweN8i8dlbRC-jTQ4yCi4X6Ot5RfBK_Z8mXSO0PyMaC2fQ3MMG4iEMGT-vsSEHnxR0ZXdl61iikuxCZVgwIvUUGvFEaAZZBg554G_z9AFBwnLimOku69V3U1p67PvtXwefkrls8d3E7L8hyezqz60Bfbbbheto1DIkt1Q
linkProvider Wiley-Blackwell
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Report+on+stage+III+Pig-a+mutation+assays+using+N-ethyl-N-nitrosourea+-+comparison+with+other+in+vivo+genotoxicity+endpoints&rft.jtitle=Environmental+and+molecular+mutagenesis&rft.au=Cammerer%2C+Zoryana&rft.au=Bhalli%2C+Javed+A&rft.au=Cao%2C+Xuefei&rft.au=Coffing%2C+Stephanie+L&rft.date=2011-12-01&rft.issn=0893-6692&rft.eissn=1098-2280&rft.volume=52&rft.issue=9&rft.spage=721&rft.epage=730&rft_id=info:doi/10.1002%2Fem.20686&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-6692&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-6692&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-6692&client=summon